Transaction marks Argano’s eighth addition since strategic growth plan began in 2025

Enhances life sciences expertise with deep Gross-to-Net, pricing, and analytics capabilities

Argano, the world’s first and largest Global Specialist Consultancy exclusively focused on the design and delivery of High-Performance Business Operations with an AI-forward approach to transformation, today announced the acquisition of Pharosity Consulting, Inc. (“Pharosity”), a firm with specialized expertise in Gross-to-Net (GTN), government pricing, commercial contracting, and advanced analytics for pharmaceutical and biotechnology companies.

The Pharosity transaction marks Argano’s eighth deal since the inception of its transformational growth program announced in April 2025, and the twenty-fourth since the company’s founding in 2020. Founded in 2015, Pharosity underscores Argano’s strategy to expand domain-specific capabilities and scale differentiated offerings. The acquisition significantly deepens Argano’s ability to help clients modernize finance, revenue, and analytics operations in highly regulated, data-intensive environments.

Pharosity delivers a structured operating model built to support complex regulatory and commercial functions with consistency and speed. Its strong command of policy-driven processes and refined delivery methods enable more resilient revenue operations and scalable compliance programs. With mature methodologies and durable client relationships, Pharosity strengthens Argano’s position as a trusted partner for transformation in highly dynamic operating environments, while also bringing a management orientation that complements and deepens Argano’s Strategic Business Consulting capabilities.

“As we move into 2026, Argano continues to build momentum through a disciplined acquisition strategy that is expanding both our scale and industry depth,” said Chip Register, Group CEO of Argano. “Pharosity's distinct specialization and proven team complement our platform well, and we’re excited to welcome them to Argano. This acquisition supports our continued focus on delivering AI-enabled high-performance operations for pharmaceutical organizations facing increasingly complex regulatory and data environments.”

Pharosity’s services are highly synergistic with Twelve Consulting Group, which joined Argano in 2025, enhancing the firm’s FP&A, ERP, and analytics solutions across the life sciences value chain. Together, they create a differentiated, end-to-end offering that combines strategic advisory, advanced analytics, and enterprise technology tailored to pharmaceutical manufacturers facing evolving regulatory and commercial demands.

For pharmaceutical, medical device, and diagnostic companies, this expanded framework enables the optimization of core operating models while supporting more effective regulatory engagement and compliance, delivered through Argano’s broader portfolio spanning business applications, AI, cloud infrastructure, data integration, and performance management.

“Joining Argano enables us to extend our reach while continuing to deliver the focused expertise our clients value,” said Brian Barbash, Co-Founder of Pharosity. “We are excited to scale within a platform that prioritizes precision, partnership, and sustainable outcomes, expanding what we can provide to our pharmaceutical clients as they navigate complexities and drive better results” he said.

This transaction closed in December 2025. Bass, Berry & Simms served as legal advisor to Argano. Ernst & Young provided financial diligence advisory. KHSA and Wipfli served as financial advisors and Messerli Kramer as legal advisor to Pharosity.

About Argano

Argano is the first and largest Global Specialist Consultancy exclusively focused on the design and delivery of High-Performance Business Operations with our AI-forward approach to transformation. We pioneer intelligent and connected solutions for our clients’ operational environments across customer engagement and service, revenue management, finance and planning, supply chain, and workforce optimization, driving both efficiency and the agility to innovate product, service, and organizational design at the speed of today’s market. Competitive advantage, cost optimization, customer satisfaction, and sustainable growth are our North Stars and our promise to our clients. Learn more at argano.com.

About Pharosity Consulting

Pharosity Consulting is a life sciences consulting firm focused on Gross-to-Net, government pricing, commercial contracting, emerging pharma operations and advanced analytics. Since 2015, Pharosity has helped pharmaceutical and biotechnology companies navigate regulatory complexity and drive performance through data-informed strategy, process improvement, and operational execution. Learn more at https://www.pharosity.com/.

Forward Looking Statements

This document contains forward-looking statements. Actual results may differ materially from those projected in any forward-looking statement. Argano has no obligation to update or revise forward-looking statements, even if circumstances change.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260127694018/en/